Trinity Biotech is a medical diagnostics company that develops, manufactures, and markets diagnostic tests for hospitals, clinical laboratories, blood banks, and alternate care settings worldwide. The company operates two principal business segments: rapid point-of-care diagnostic tests for infectious diseases, hemoglobin variants, cardiac markers, pregnancy, and general chemistry applications; and a licensed U.S. reference laboratory providing testing services including HIV, hepatitis C, blood screening, and genomic testing to institutional customers and insurance companies. Trinity generates revenue through sales of diagnostic devices and reagents, laboratory testing services, and instrument leasing arrangements, with the majority of revenues derived from export markets outside the United States.
| USD millions | FY2024 |
|---|---|
| Revenue | 62 |
| Net Income | -32 |